Team:Glasgow/PathwayTools/Intro

From 2011.igem.org

(Difference between revisions)
Line 1: Line 1:
{{Team:Glasgow/Header}}
{{Team:Glasgow/Header}}
<html><h1>Tools for Pathway Engineering</h1>
<html><h1>Tools for Pathway Engineering</h1>
-
The modular nature of synthetic biology makes it ideal for pathway engineering for the purpose of compound manufactureHowever there are a number of factors to consider when synthesizing compounds, chief of which is the precise control of protein expression levels. <br/><br/>
+
The modular nature of synthetic biology makes it ideal for pathway engineering for the purpose of compound productionThis means that engineered microorganisms can be used to manufacture a variety of useful chemicals, ranging from intermediates along a particular pathway (such as the  Opiate Pathway or Isoprenols) to specific vitamins.  <br/><Br/>
-
Expression of all genes within the pathway at the optimum level is key.  
+
When engineering a pathway, there are many considerations such as correctly inserting the pathway genes into your chosen host organism. However one of the most important considerations is the precise control of protein expression levels.<Br/><br/>
-
<center><img src=https://static.igem.org/mediawiki/2011/f/fe/Glasgowpathway.png></center>
+
If the protein is over expressing, it can have detrimental effects on the levels of cellular resources and may even be cytotoxic.  If the protein is under expressing, then it will cause practical problems for the overall yield. <br/>
-
  If one of the enzymes in this pathway is rate limiting, then a buildup of intermediate products can be extremely undesirable for the cell. Not only is it a waste of resources, but the compound may be cytotoxic.  <br/><br/>
+
<center><img src=https://static.igem.org/mediawiki/2011/f/fe/Glasgowpathway.png></center><br/>
 +
However both these situations may occur at separate points along a pathway. This is why it is essential to ensure that gene expression over the whole pathway is optimal for the system. <br/><br/>
 +
One way of controlling the flux through pathways is to engineer the strength of promoters and ribosome binding sites (RBSs) to regulate gene expression. These can be used in a modular combinatorial approach to create diverse variations of the pathway of interest.
-
One way of controlling the flux through pathways is to engineer the strength of promoters and ribosome binding sites (RBSs) to regulate gene expression. These can be used in a modular combinatorial approach to create diverse variations of the pathway of interest. <br/><br/>
+
To this end we have created a library of combined promoters and RBS of different strengths in biobrick format which can be used to create and test different expression levels of individual metabolic pathway genes for optimum product formation.<br/><Br/>
-
To this end we have created a library of combined promoters and RBS of different strengths in biobrick format which can be used to create and test different expression levels of individual metabolic pathway genes for optimum product formation.<br/><br/>
+
We have also created a Multiple Cloning site biobrick. It contains a double terminator and five restriction sites, so is ideal for use with our library of promoters.  The aim of this biobrick is to significantly simplify the testing of genes by reducing the number of overall ligations that must be performed.<br/><br/>
We have also created a Multiple Cloning site biobrick. It contains a double terminator and five restriction sites, so is ideal for use with our library of promoters.  The aim of this biobrick is to significantly simplify the testing of genes by reducing the number of overall ligations that must be performed.<br/><br/>
To read more about the creation of the Promoter + RBS library, click <a href=https://2011.igem.org/Team:Glasgow/Results/PromoterLibrary>here.</a><br/>
To read more about the creation of the Promoter + RBS library, click <a href=https://2011.igem.org/Team:Glasgow/Results/PromoterLibrary>here.</a><br/>
To read more about the creation of the Multiple Cloning Site, click <a href=https://2011.igem.org/Team:Glasgow/Results/MCS>here.</a>
To read more about the creation of the Multiple Cloning Site, click <a href=https://2011.igem.org/Team:Glasgow/Results/MCS>here.</a>

Revision as of 01:38, 22 September 2011

Tools for Pathway Engineering

The modular nature of synthetic biology makes it ideal for pathway engineering for the purpose of compound production. This means that engineered microorganisms can be used to manufacture a variety of useful chemicals, ranging from intermediates along a particular pathway (such as the Opiate Pathway or Isoprenols) to specific vitamins.

When engineering a pathway, there are many considerations such as correctly inserting the pathway genes into your chosen host organism. However one of the most important considerations is the precise control of protein expression levels.

If the protein is over expressing, it can have detrimental effects on the levels of cellular resources and may even be cytotoxic. If the protein is under expressing, then it will cause practical problems for the overall yield.

However both these situations may occur at separate points along a pathway. This is why it is essential to ensure that gene expression over the whole pathway is optimal for the system.

One way of controlling the flux through pathways is to engineer the strength of promoters and ribosome binding sites (RBSs) to regulate gene expression. These can be used in a modular combinatorial approach to create diverse variations of the pathway of interest. To this end we have created a library of combined promoters and RBS of different strengths in biobrick format which can be used to create and test different expression levels of individual metabolic pathway genes for optimum product formation.

We have also created a Multiple Cloning site biobrick. It contains a double terminator and five restriction sites, so is ideal for use with our library of promoters. The aim of this biobrick is to significantly simplify the testing of genes by reducing the number of overall ligations that must be performed.

To read more about the creation of the Promoter + RBS library, click here.
To read more about the creation of the Multiple Cloning Site, click here.